JPMorgan Chase & Co (JPM)vsTexas Capital Bancshares, Inc. (TCBIO)
JPM
JPMorgan Chase & Co
$340.07
-3.42%
FINANCIAL SERVICES · Cap: $946.93B
TCBIO
Texas Capital Bancshares, Inc.
$19.28
-1.18%
FINANCIAL SERVICES · Cap: $3.31B
Smart Verdict
WallStSmart Research — data-driven comparison
JPMorgan Chase & Co generates 14568% more annual revenue ($186.33B vs $1.27B). JPM leads profitability with a 34.9% profit margin vs 28.7%. TCBIO trades at a lower P/E of 5.0x. JPM earns a higher WallStSmart Score of 81/100 (A-).
JPM
Exceptional Buy81
out of 100
Grade: A-
TCBIO
Hold48
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Keeps 35 of every $100 in revenue as profit
Strong operational efficiency at 50.4%
Revenue surging 30.4% year-over-year
Attractively priced relative to earnings
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 36.7%
Keeps 29 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Negative free cash flow — burning cash
Distress zone — elevated risk
Elevated debt levels
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : JPM
The strongest argument for JPM centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 34.9% and operating margin at 50.4%. Revenue growth of 30.4% demonstrates continued momentum.
Bull Case : TCBIO
The strongest argument for TCBIO centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 28.7% and operating margin at 36.7%.
Bear Case : JPM
The primary concerns for JPM are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.30 is elevated, increasing financial risk.
Bear Case : TCBIO
The primary concerns for TCBIO are Altman Z-Score.
Key Dynamics to Monitor
JPM profiles as a growth stock while TCBIO is a mature play — different risk/reward profiles.
JPM carries more volatility with a beta of 0.97 — expect wider price swings.
JPM is growing revenue faster at 30.4% — sustainability is the question.
TCBIO generates stronger free cash flow (97M), providing more financial flexibility.
Bottom Line
JPM scores higher overall (81/100 vs 48/100), backed by strong 34.9% margins and 30.4% revenue growth. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
JPMorgan Chase & Co
FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA
JPMorgan Chase & Co. is an American multinational investment bank and financial services holding company headquartered in New York City. JPMorgan Chase is incorporated in Delaware. As a Bulge Bracket bank, it is a major provider of various investment banking and financial services. It is one of America's Big Four banks, along with Bank of America, Citigroup, and Wells Fargo. JPMorgan Chase is considered to be a universal bank and a custodian bank. The J.P. Morgan brand is used by the investment banking, asset management, private banking, private wealth management, and treasury services divisions.
Visit Website →Texas Capital Bancshares, Inc.
FINANCIAL SERVICES · BANKS - REGIONAL · USA
Texas Capital Bancshares, Inc. (TCBIO), headquartered in Dallas, Texas, is a leading regional bank that provides a comprehensive suite of financial services to both commercial and individual clients. The bank excels in delivering customized solutions, including business lending, treasury management, and personal banking, underpinned by a strong focus on client relationships and local market knowledge. With a strategic emphasis on prudent risk management and sustainable growth, TCBIO is optimally positioned to thrive in the competitive banking landscape while enhancing long-term shareholder value.
Compare with Other BANKS - DIVERSIFIED Stocks
Want to dig deeper into these stocks?